Med-Con Technologies News
Med-Con Technologies is supporting a major pharmaceutical company to reach optimal levels of patient adherence in a global clinical trial.
In a multi-country/multi-lingual clinical trial, Med-Con Technologies’ adherence solution - Med-Con Mobile Smart Label - is designed to assist patients to more effectively self-manage their medication away from the supervised environment. In addition, the information our application collects may assist sites to identify the optimal dose strength.
Med-Con Technologies QMS/GxP Audit Validation.
In a recent audit by Bayer AG, Med-Con Technologies successfully completed an extensive review to validate its company QMS processes and GxP procedures. This was our fourth audit and we have demonstrated solid procedures for important components as: change and risk management, and SDLC. Med-Con Technologies also successfully completed an audit by Thermo Fisher Scientific for its Quality Management Systems and GCP processes.
Med-Con Technologies Signed Contract with Thermo Fisher.
Med-Con Technologies and Thermo Fisher have signed a Master Services Agreement, and Thermo Fisher will add Med-Con Mobile Smart Label and Med-Con Central Software to its portfolio of digital adherence solutions.